Tasso, Inc. Joint Venture Receives Controlled Medical Device Approval in Japan for Novel Self-Administered Blood Collection Device
Certification clears path in Japan for wider access to preventive medicine, telemedicine, and reduced provider burden SEATTLE – September 9, 2025 – Tasso, Inc., the leading provider of patient-centric, clinical-grade blood collection solutions, today announced that the TS Blood Collection... Read More →
Akeyna’s Smart Needle: Worcester Startup in Auxilium Cohort Targets Safer Injections
WORCESTER, MA-Karen Cronholm, the CEO of Akeyna, Inc., and part of the historic first cohort of Auxilium stops by the Talk of the Commonwealth to tell us about her business and how Auxilium is providing assistance. Cronholm discussed her company’s... Read More →
CHO Plus Obtains U.S. Patent for Improved Production of Proteins Using Engineered Yeast Cells
Cell Engineering Technology Will Increase Recombinant Protein Production for Food Ingredients, Industrial Enzymes, and Other Products SOUTH SAN FRANCISCO, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) — CHO Plus, Inc. (www.CHO-Plus.com), a leading developer of biopharmaceutical manufacturing technology, announced that U.S.... Read More →
cellvie secures $5 Million in fresh capital from existing and new investors
Zurich, Switzerland – September 9th, 2025 – cellvie, a company pioneering therapeutics based on mitochondria, today announced the closing of a $5 million funding round, with participation from both existing and new investors. The round was led by Taiho Ventures,... Read More →
Koya Medical Receives “Building Tomorrow Together” Award from Dallas Regional Chamber
Innovative vascular health company recognized for commitment to growth, innovation, and community impact in North Texas DALLAS, Sept. 9, 2025 /PRNewswire/ — Koya Medical (“Koya”), a global leader in vascular health innovation, is proud to announce it has been honored... Read More →
MY01 Welcomes Joe Kiani as Investor and Board Member to Accelerate Innovation in Connected Patient Monitoring
MONTREAL, Sept. 8, 2025 /PRNewswire/ — MY01, an innovative medical technology company focused on transforming the diagnosis of limb perfusion injuries, today announced that Joe Kiani, founder of Masimo and a globally recognized leader in medical innovation, has invested in... Read More →
Cerillo to launch Rayo: Next-Gen Multiwavelength Microplate Reader at Analytica USA 2025
CHARLOTTESVILLE, Va., Sept. 8, 2025 /PRNewswire/ — Cerillo, pioneer in compact microplate reader technology, is proud to announce the launch of Rayo, its newest multiwavelength platform for ELISA assays, protein quantification, and kinetic growth curves for plant, algae, and microbial... Read More →
OrthoPediatrics Corp. Announces Distribution Agreement with MY01 Inc.
WARSAW, Ind., Sept. 05, 2025 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics announced today a new distribution partnership with MY01, an innovative medical technology company focused on transforming the... Read More →
Edwards buys remaining stake of Vectorious Medical Technologies and its heart implant
According to a report in Globes, Edwards Lifesciences (NYSE: EW)+ agreed to acquire the remaining stake in Vectorious Medical Technologies. The report states that Edwards’ deal values Vectorious at $497 million. It executed the acquisition in two stages, the report... Read More →
Ways to Improve Osteopenia with Osteoboost
It is exciting when new products come to market that speak directly to our demographic. Our guest this week, is Laura Yecies, CEO of Osteoboost. Osteoboost is the first FDA-cleared drug-free prescription treatment for osteopenia in postmenopausal women. How does... Read More →